These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36912629)

  • 1. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
    Rimal B; Nicklas DA; Panthi CM; Lippincott CK; Belz DC; Ignatius EH; Deck DH; Serio AW; Lamichhane G
    mSphere; 2023 Apr; 8(2):e0066522. PubMed ID: 36912629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of
    Ignatius EH; Rimal B; Panthi CM; Belz DC; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    mSphere; 2024 Jul; 9(7):e0038124. PubMed ID: 38980071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.
    Rimal B; Panthi CM; Xie Y; Belz DC; Ignatius EH; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    Tuberculosis (Edinb); 2024 May; 146():102482. PubMed ID: 38364332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates
    Nicklas DA; Maggioncalda EC; Story-Roller E; Eichelman B; Tabor C; Serio AW; Keepers TR; Chitra S; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170421. PubMed ID: 34662184
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice.
    Sriram D; Wahi R; Maggioncalda EC; Panthi CM; Lamichhane G
    Tuberculosis (Edinb); 2022 Dec; 137():102268. PubMed ID: 36228452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 8. Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
    Wang S; Cai X; Yu W; Zeng S; Zhang J; Guo L; Gao Y; Lu Z; Hameed HMA; Fang C; Tian X; Yusuf B; Chhotaray C; Alam MDS; Zhang B; Ge H; Maslov DA; Cook GM; Peng J; Lin Y; Zhong N; Zhang G; Zhang T
    Microbiol Spectr; 2022 Aug; 10(4):e0276321. PubMed ID: 35946941
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
    Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Fujiwara K; Aono A; Asami T; Morimoto K; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Mitarai S
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157922. PubMed ID: 37154742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for
    Moore RE; Millar BC; Panickar JR; Moore JE
    Int J Mycobacteriol; 2018; 7(3):257-260. PubMed ID: 30198506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
    Kang N; Jeon K; Kim H; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ; Jhun BW
    Chest; 2021 Aug; 160(2):436-445. PubMed ID: 33621600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential
    Lee J; Ammerman N; Agarwal A; Naji M; Li SY; Nuermberger E
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168614
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866869
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Martins O; Lee J; Kaushik A; Ammerman NC; Dooley KE; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0154521. PubMed ID: 34516254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omadacycline therapy for Mycobacterium abscessus species infections.
    Ingram PR; Jones EE; Allen B; Murray RJ; Keehner TJ; Whitmore TJ
    Intern Med J; 2023 Dec; 53(12):2257-2263. PubMed ID: 36917124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.
    Singh S; Wang JY; Heysell SK; McShane PJ; Wadle C; Shankar P; Huang HL; Pasipanodya J; Boorgula GD; Philley JV; Gumbo T; Srivastava S
    Int J Antimicrob Agents; 2023 Jul; 62(1):106847. PubMed ID: 37187338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.
    Story-Roller E; Galanis C; Lamichhane G
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33361310
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G; Wu L; Zheng Q; Jiang X
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex.
    Shirata M; Yoshimoto Y; Marumo S; Tamai K; Fukui M
    Int J Infect Dis; 2020 Aug; 97():270-277. PubMed ID: 32526389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.